drugset / Trial / NCT01393678

Study to Evaluate Efficacy and Safety of PENNEL Capsule in the Patients With Chronic Liver Disease

NCT01393678

Phase 3 Completed 220 enrolled PharmaKing
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The drug in this study is combined product of biphenyl dimethyl dicarboxylate (DDB) and garlic oil. This components showed synergistic enhancing effects in previous tests. In phase 2 test, 6 cap three times a day dosage (2cap T.I.D) is better than other dosage. Based on above, this study is phase 3 test to prove efficacy and safety of PENNEL.

Timeline

Start
1997-11
Primary completion
1998-03
Completion
1998-05

Drugs

EvaluationDrugModalityDoseRoute
Subject garlic oil Traditional medicine (herbal / TCM) 50 mg
Comparator Biphenyl Dimethyl Dicarboxylate Small molecule 25 mg

Indications